Evidence map›Paper›PMID 18063416›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2008

American founder mutation for attenuated familial adenomatous polyposis.

Deborah W Neklason, Jeffery Stevens, Kenneth M Boucher, Richard A Kerber, Nori Matsunami, Jahn Barlow, Geraldine Mineau, Mark F Leppert, Randall W Burt

Abstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Deborah W NeklasonDepartment of Oncological Sciences, University of Utah, Salt Lake City, Utah 84112-5550, USA. deb.neklason@hci.utah.edu
Jeffery Stevens
Kenneth M Boucher
Richard A Kerber
Nori Matsunami
Jahn Barlow
Geraldine Mineau
Mark F Leppert
Randall W Burt
University of Utah · USHuntsman Cancer Institute · US

Funding

TCF/LEF function during intestinal maintenance and colon tumorigenesisP01CA073992 · NCI · UNIVERSITY OF UTAH · PI CAPECCHI, MARIO R · 1998 to 2014
$29.7M
INHERITANCE OF DISCRETE COLORECTAL ADENOMATOUS POLYPSR01CA040641 · NCI · UNIVERSITY OF UTAH · PI BURT, RANDALL WALTER · 1985 to 2007
$2.5M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01CN067000 · CN · UNIVERSITY OF UTAH · PI STANFORD, JANET L · 1996 to 1997
–
NCI NIH HHS N01 CN067000NCI NIH HHS NCI-CN-67000NCI NIH HHS P01 CA073992NCI NIH HHS P01-CA073992NCI NIH HHS R01 CA040641NCI NIH HHS R01-CA040641
6 · The paper itself

Abstract

BACKGROUND &

aimsSpecific mutations in the adenomatous polyposis coli (APC) gene can lead to an attenuated form of familial adenomatous polyposis (AFAP). Although AFAP mutation carriers have a 69% risk of colorectal cancer by age 80, clinical recognition remains a challenge in some cases because they present with few colonic adenomas and are difficult to distinguish clinically from patients with sporadic polyps.

methodsFamily relationships were established using family history reports, the Utah Population Database, and the public records of the Mormon Church. Genetic analysis of representative family members was performed using a 10,000 single nucleotide polymorphism array platform. Colonoscopy data were available on 120 individuals with the AFAP mutation.

resultsTwo large AFAP kindreds with the identical APC disease-causing mutation (c.426_427delAT) were linked to a founding couple who came to America from England around 1630. Genetic analysis showed that the 2 families share a conserved haplotype of 7.17 Mbp surrounding the mutant APC allele. The data show that 36.6% of the mutation-positive family members have fewer than 10 colonic adenomatous polyps, and 3 (6.8%) of these individuals were diagnosed with colorectal cancer.

conclusionsIn view of the apparent age of this mutation, a notable fraction of both multiple-adenoma patients and perhaps even colon cancer cases in the United States could be related to this founder mutation. The colon cancer risk associated with the mutation makes genetic testing of considerable importance in patients with a personal or family history of either colonic polyps or cancer at a young age.

Indexed as

Founder EffectGenes, APCMutationAdenomatous Polyposis ColiColorectal NeoplasmsGenetic LinkageGenetics, PopulationHaplotypesHumansPedigreePolymorphism, Single NucleotideUtah

Identifiers

PMID18063416
PMCPMC2245898
OpenAlexW2128443346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.